Carlos Enrique, R. Pérez, Representante Legal, Estado DE Resultados
{"title":"结果","authors":"Carlos Enrique, R. Pérez, Representante Legal, Estado DE Resultados","doi":"10.4272/84-9745-020-5.ch5","DOIUrl":null,"url":null,"abstract":"Introduction and objectives: We describe the results for Spain of the Second European Cardiac Resynchronization Therapy Survey (CRT-Survey II) and compare them with those of the other participating countries. Methods: We included patients undergoing CRT device implantation between October 2015 and December 2016 in 36 participating Spanish centers. We registered the patients’ baseline characteristics, implant procedure data, and short-term follow-up information until hospital discharge. Results: Implant success was achieved in 95.9%. The median [interquartile range] annual implantation rate by center was significantly lower in Spain than in the other participating countries: 30 implants/y [21-50] vs 55 implants/y [33-100]; P = .00003. In Spanish centers, there was a lower proportion of patients (cid:3) 75 years (27.9% vs 32.4%; P = .0071), a higher proportion in NYHA class II (46.9% vs 36.9%, P < .00001), and a higher percentage with electrocardiographic criteria of left bundle branch block (82.9% vs 74.6%; P < .00001). The mean length of hospital stay was significantly lower in Spanish centers (5.8 (cid:4) 8.5 days vs 6.4 (cid:4) 11.6; P < .00001). Spanish patients were more likely to receive a quadripolar LV lead (74% vs 56%, P < .00001) and to be followed up by remote monitoring (55.8% vs 27.7%; P < .00001). Conclusions: The CRT-Survey II shows that, compared with other participating countries, fewer patients in Spain aged (cid:3) 75 years received a CRT device, while more patients were in New York Heart Association functional class II and had left bundle branch block.","PeriodicalId":331458,"journal":{"name":"La situación de los esports en España. Una Perspectiva Cualitativa","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2016-01-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"RESULTADOS\",\"authors\":\"Carlos Enrique, R. Pérez, Representante Legal, Estado DE Resultados\",\"doi\":\"10.4272/84-9745-020-5.ch5\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Introduction and objectives: We describe the results for Spain of the Second European Cardiac Resynchronization Therapy Survey (CRT-Survey II) and compare them with those of the other participating countries. Methods: We included patients undergoing CRT device implantation between October 2015 and December 2016 in 36 participating Spanish centers. We registered the patients’ baseline characteristics, implant procedure data, and short-term follow-up information until hospital discharge. Results: Implant success was achieved in 95.9%. The median [interquartile range] annual implantation rate by center was significantly lower in Spain than in the other participating countries: 30 implants/y [21-50] vs 55 implants/y [33-100]; P = .00003. In Spanish centers, there was a lower proportion of patients (cid:3) 75 years (27.9% vs 32.4%; P = .0071), a higher proportion in NYHA class II (46.9% vs 36.9%, P < .00001), and a higher percentage with electrocardiographic criteria of left bundle branch block (82.9% vs 74.6%; P < .00001). The mean length of hospital stay was significantly lower in Spanish centers (5.8 (cid:4) 8.5 days vs 6.4 (cid:4) 11.6; P < .00001). Spanish patients were more likely to receive a quadripolar LV lead (74% vs 56%, P < .00001) and to be followed up by remote monitoring (55.8% vs 27.7%; P < .00001). Conclusions: The CRT-Survey II shows that, compared with other participating countries, fewer patients in Spain aged (cid:3) 75 years received a CRT device, while more patients were in New York Heart Association functional class II and had left bundle branch block.\",\"PeriodicalId\":331458,\"journal\":{\"name\":\"La situación de los esports en España. Una Perspectiva Cualitativa\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2016-01-22\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"La situación de los esports en España. Una Perspectiva Cualitativa\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.4272/84-9745-020-5.ch5\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"La situación de los esports en España. Una Perspectiva Cualitativa","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4272/84-9745-020-5.ch5","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
介绍和目的:我们描述了西班牙第二次欧洲心脏再同步化治疗调查(CRT-Survey II)的结果,并将其与其他参与国家的结果进行了比较。方法:我们纳入了2015年10月至2016年12月在36个西班牙中心接受CRT装置植入的患者。我们记录了患者的基线特征、植入手术数据和出院前的短期随访信息。结果:种植成功率95.9%。西班牙中心的年种植率中位数[四分位数范围]明显低于其他参与国:30个种植体/年[21-50]vs 55个种植体/年[33-100];P = 0.003。在西班牙中心,75岁患者(cid:3)的比例较低(27.9% vs 32.4%;P = 0.0071), NYHA II级比例更高(46.9% vs 36.9%, P < 0.00001),左束支传导阻滞的心电图标准比例更高(82.9% vs 74.6%;P < 0.001)。西班牙中心的平均住院时间明显较低(5.8 (cid:4) 8.5天vs 6.4 (cid:4) 11.6天;P < 0.001)。西班牙患者更有可能接受四极左室导联(74%对56%,P < 0.00001),并接受远程监测随访(55.8%对27.7%;P < 0.001)。结论:ct - survey II显示,与其他参与国相比,西班牙75岁(cid:3)患者较少接受CRT装置,而纽约心脏协会功能II级患者较多,左束支传导阻滞。
Introduction and objectives: We describe the results for Spain of the Second European Cardiac Resynchronization Therapy Survey (CRT-Survey II) and compare them with those of the other participating countries. Methods: We included patients undergoing CRT device implantation between October 2015 and December 2016 in 36 participating Spanish centers. We registered the patients’ baseline characteristics, implant procedure data, and short-term follow-up information until hospital discharge. Results: Implant success was achieved in 95.9%. The median [interquartile range] annual implantation rate by center was significantly lower in Spain than in the other participating countries: 30 implants/y [21-50] vs 55 implants/y [33-100]; P = .00003. In Spanish centers, there was a lower proportion of patients (cid:3) 75 years (27.9% vs 32.4%; P = .0071), a higher proportion in NYHA class II (46.9% vs 36.9%, P < .00001), and a higher percentage with electrocardiographic criteria of left bundle branch block (82.9% vs 74.6%; P < .00001). The mean length of hospital stay was significantly lower in Spanish centers (5.8 (cid:4) 8.5 days vs 6.4 (cid:4) 11.6; P < .00001). Spanish patients were more likely to receive a quadripolar LV lead (74% vs 56%, P < .00001) and to be followed up by remote monitoring (55.8% vs 27.7%; P < .00001). Conclusions: The CRT-Survey II shows that, compared with other participating countries, fewer patients in Spain aged (cid:3) 75 years received a CRT device, while more patients were in New York Heart Association functional class II and had left bundle branch block.